0.82
Enlivex Ltd (ENLV) 最新ニュース
Enlivex (ENLV) price target increased by 53.85% to 20.40 - MSN
Enlivex Therapeutics (ENLV) price target decreased by 30.00% to 7.14 - MSN
If You Invested $1,000 in Enlivex Ltd (ENLV) - Stock Titan
Volume Recap: Is now the right time to enter Enlivex Therapeutics Ltd2026 Earnings Impact & Community Consensus Stock Picks - baoquankhu1.vn
ENLV SEC FilingsEnlivex Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Enlivex Shares Tokenized on Ondo Global Markets to Expand Global Digital Investor Access - TipRanks
Ondo Global Markets Tokenizes Enlivex’s Ordinary Shares - The Manila Times
Ondo tokenizes Enlivex (Nasdaq: ENLV) shares for global digital access - Stock Titan
Ondo Global Markets Tokenizes Enlivex's Ordinary Shares - 富途牛牛
Rain Crypto Jump On Red Market: Big Pharma Enlivex Raised $21M Treasury - 99Bitcoins
ENLV Stock Rating: HC Wainwright & Co. Raises Price Target to $2 - GuruFocus
Enlivex shares jump after earnings as treasury gains boost results - MSN
ENLV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
ENLV PE Ratio & Valuation, Is ENLV Overvalued - Intellectia AI
Enlivex clears pivotal FDA hurdle in knee osteoarthritis - Longevity.Technology
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Progress Index
Market Wrap: What analysts say about Enlivex Therapeutics Ltd stock2026 Big Picture & Technical Entry and Exit Tips - baoquankhu1.vn
Enlivex Therapeutics (NASDAQ:ENLV) Stock Rating Lowered by Wall Street Zen - MarketBeat
Enlivex Announces $21M Debt Financing and Prediction Markets Treasury Expansion - Bitcoin.com News
RAIN Token Climbs to 25th in Market Cap Following Institutional Activity and Protocol Upgrades - Bitget
Enlivex Therapeutics Tokenized Stock (Ondo) price today, ENLVon to USD live price, marketcap and chart - CoinMarketCap
Enlivex Posts $1.23B Profit (Net Income) For Fiscal 2025 - NewMediaWire
Enlivex Posts $1.23B Profit (Net Income) For Fiscal 2025 | Corporate - EQS News
Published on: 2026-03-26 22:45:56 - baoquankhu1.vn
Enlivex Reports Full-Year 2025 Results, Profit of $1.23 Billion and Diluted Earnings per Share of $25.48 - marketscreener.com
Enlivex Posts $1.23 Billion Profit for 2025 on Treasury Asset Gains - The Globe and Mail
Enlivex Highlights Rain’s AI Agent Launch and $5 Million Grant Program to Expand Prediction Markets - tipranks.com
Enlivex Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt - manilatimes.net
Enlivex (NASDAQ: ENLV) highlights Rain AI launch, $5M grants and RAIN token burn - Stock Titan
One prompt can now create a live prediction market as Rain adds $5M - Stock Titan
Enlivex Obtains $21 Million Loan to Purchase RAIN Tokens and Initiate $20 Million Buyback - Bitget
Earnings call transcript: Enlivex Q4 2025 sees stock surge on treasury gains - Investing.com Australia
Envilex Therapeutics (ENLV) Reports Strong FY GAAP EPS - GuruFocus
Enlivex Soars After FDA Approval for Allocetra Trial - StocksToTrade
Enlivex Stock Boosted by FDA Approval for Allocetra in Osteoarthritis Trials - timothysykes.com
Enlivex Therapeutics Q4 Earnings Call Highlights - marketbeat.com
Enlivex Allocetra Takes A Leap as FDA Clears Phase 2b Trial for Osteoarthritis - timothysykes.com
Enlivex Reports Full-Year 2025 Results: Profit (Net Income) of $1.23 Billion and Diluted Earnings Per Share (EPS) of $25.48 - Bitget
Enlivex Secures $21 Million Convertible Debt, Expands RAIN Token Holdings and Launches $20 Million Buyback - The Globe and Mail
Enlivex Therapeutics (NASDAQ:ENLV) Releases Earnings Results, Beats Estimates By $12.88 EPS - MarketBeat
Enlivex Ltd. Reports $1.23 Billion Net Income for 2025 Driven by Treasury Asset Appreciation - Quiver Quantitative
大文字化:
|
ボリューム (24 時間):